Paramedic Papers

Home Obstetrics Severe hypertension in pregnancy rarely treated to guideline

Obstetrics

Severe hypertension in pregnancy rarely treated to guideline

Prevalence of Persistent Severe Hypertension and Rates of Treatment Among Pregnant Patients in the Prehospital Setting
Prehospital Emergency Care · 2026-10-30 · Added 31 October 2026

A US national EMS dataset study of 39,546 responses for pregnant patients beyond 20 weeks found persistent severe hypertension in 3.1%, of whom only 0.8% received guideline-adherent treatment with both magnesium and an antihypertensive.

Study type
Cohort
Design
Retrospective observational cohort (2024 ESO Data Collaborative)
Participants
39,546 EMS scene responses for pregnancy beyond 20 weeks
Main finding
Persistent severe hypertension in 3.1% (1,234/39,546); of those, 6.2% received magnesium only, 1.5% an antihypertensive only, and 0.8% both magnesium and an antihypertensive
Caveat
US retrospective dataset, and treatment rates pre-date the 2025 ACOG-NAEMSP prehospital guideline
Bottom line
Hypothesis-generating

Why it matters in Australia (Medium relevance). Magnesium for pre-eclampsia sits in nearly every Australian formulary, but the paired antihypertensive the new US guideline wants is carried by only a handful of services, so the full pathway doesn't transfer yet.

Learning goal

Recognise persistent severe hypertension in pregnancy as a prehospital risk requiring timely treatment decisions.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Obstetrics